The DOI matches its Crossref record; 188 of the 188 references it cites were found in a registry or an index.
The two faces of protein misfolding: gain‐ and loss‐of‐function in neurodegenerative diseases
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769 · cited 1×
“These in vivo generated oligomeric assem- blies can be as small as dimers or trimers (Podlisny et al, 1995) or as large as dodecamers (Lesne et al, 2006).”
BackgroundRetractedThe Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · cited 1×
“…mutations as well as genomic multiplications promote the propensity of a-synuclein to aggregate and are associated with autosomal dominant PD (Polymeropoulos et al, 1997; Kruger et al, 1998; Singleton et al, 2003; Chartier-Harlin et al, 2004; Farrer et al, 2004; Ibanez et al, 2004; Zarranz…”
BackgroundUbiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227 · cited 2×
“Mutations in parkin, a gene encoding an E3 ubiquitin ligase (Kitada et al, 1998), are responsible for the majority of autosomal recessive PD (Figure 1C).”
BackgroundNovel Proteinaceous Infectious Particles Cause Scrapie
Prusiner, S. B. (1982) · Science · doi:10.1126/science.6801762 · Cited by 5,118
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744 · cited 15×
“lead to mild cognitive impairment (MCI) at early stages of AD (Haass and Selkoe, 2007).”
BackgroundResultInfluentialSelf-citationα-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology
Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., Uitti, R. J., Calne, D. B., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.11.005 · Cited by 3,005
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibanez, P., Joosse, M., et al. (2003) · Science · doi:10.1126/science.1077209 · Cited by 2,778
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737
Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease
Paisán-Ruı́z, C., Jain, S., Evans, E. W., Gilks, W. P., Simón, J., van der Brug, M., de Munain, A. L., Aparicio, S., Gil, A. M., Khan, N., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.10.023 · Cited by 2,405
Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders
Ballatore, C., Lee, V. M.-Y., & Trojanowski, J. Q. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2194 · Cited by 2,174
Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
Baker, M., Mackenzie, I. R., Pickering-Brown, S. M., Gass, J., Rademakers, R., Lindholm, C., Snowden, J., Adamson, J., Sadovnick, A. D., Rollinson, S., et al. (2006) · Nature · doi:10.1038/nature05016 · Cited by 2,058
α-synuclein locus duplication as a cause of familial Parkinson's disease
Chartier-Harlin, M.-C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., Levecque, C., Larvor, L., Andrieux, J., Hulihan, M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17103-1 · Cited by 2,029
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024 · cited 1×
“…impairment of proteasomal or lysoso- mal protein degradation (Stefanis et al, 2001; Tanaka et al, 2001; Petrucelli et al, 2002; Snyder et al, 2003; Cuervo et al, 2004; Lindersson et al, 2004), induction of endoplasmic reticulum (ER) stress (Smith et al, 2005; Cooper et al, 2006), Golgi…”
BackgroundReducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007) · Science · doi:10.1126/science.1141736 · Cited by 1,892
Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin
Clark, I. E., Dodson, M. W., Jiang, C., Cao, J. H., Huh, J. R., Seol, J. H., Yoo, S. J., Hay, B. A., & Guo, M. (2006) · Nature · doi:10.1038/nature04779 · Cited by 1,788
Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin
Park, J., Lee, S. B., Lee, S., Kim, Y., Song, S., Kim, S., Bae, E., Kim, J., Shong, M., Kim, J.-M., et al. (2006) · Nature · doi:10.1038/nature04788 · Cited by 1,705 · cited 1×
“Remarkably, parkin can compensate for the loss of PINK1 function, but not vice versa, suggesting that parkin acts downstream of PINK1 (Clark et al, 2006; Park et al, 2006; Yang et al, 2006).”
BackgroundEnhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP
Lewis, J., Dickson, D. W., Lin, W.-L., Chisholm, L., Corral, A., Jones, G., Yen, S.-H., Sahara, N., Skipper, L., Yager, D., et al. (2001) · Science · doi:10.1126/science.1058189 · Cited by 1,611
Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils
Götz, J., Chen, F., van Dorpe, J., & Nitsch, R. M. (2001) · Science · doi:10.1126/science.1062097 · Cited by 1,526 · cited 1×
“A strong support of a direct induction of tau pathology by Ab came from the observation that pathological phosphorylation of tau is induced by the intracerebral injection of Ab42 fibrils (Gotz et al, 2001).”
BackgroundCruts, M., Gijselinck, I., van der Zee, J., Engelborghs, S., Wils, H., Pirici, D., Rademakers, R., Vandenberghe, R., Dermaut, B., Martin, J.-J., et al. (2006) · Nature · doi:10.1038/nature05017 · Cited by 1,512 · cited 2×
“Apparently, all these mutations result in the degradation of the mutant mRNA by nonsense- mediated mRNA decay (Baker et al, 2006; Cruts et al, 2006).”
BackgroundWatts, G. D. J., Wymer, J., Kovach, M. J., Mehta, S. G., Mumm, S., Darvish, D., Pestronk, A., Whyte, M. P., & Kimonis, V. E. (2004) · Nature Genetics · doi:10.1038/ng1332 · Cited by 1,391 · cited 1×
“…genes and an uncharacterized locus on chromosome 9p have been linked to familial FTLD-U: the valosin-containing protein (VCP) gene on chromosome 9 (Watts et al, 2004), the charged multivesicular body protein 2B gene (CHMP2B) on chromosome 3 (Skibinski et al, 2005) and the progranulin gene (PGRN)…”
BackgroundA subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. E., Murphy, M. P., Bulter, T., et al. (2001) · Nature · doi:10.1038/35102591 · Cited by 1,388 · cited 12×
“Familial AD (FAD)-associated muta- tions shift the cleavage from position 40 to position 42 of the Ab domain to produce a more aggregation prone Ab species (Ab42) or at least increase the ratio of Ab42/Ab40 (Haass and Selkoe, 2007).”
BackgroundInfluentialα-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson's Models
Cooper, A. A., Gitler, A. D., Cashikar, A., Haynes, C. M., Hill, K. J., Bhullar, B., Liu, K., Xu, K., Strathearn, K. E., Liu, F., et al. (2006) · Science · doi:10.1126/science.1129462 · Cited by 1,376
Amyloid pores from pathogenic mutations
Lashuel, H. A., Hartley, D., Petre, B. M., Walz, T., & Lansbury, P. T. (2002) · Nature · doi:10.1038/418291a · Cited by 1,289
MOLECULAR PATHOPHYSIOLOGY OF PARKINSON'S DISEASE
Moore, D. J., West, A. B., Dawson, V. L., & Dawson, T. M. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135718 · Cited by 1,280
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
West, A. B., Moore, D. J., Biskup, S., Bugayenko, A., Smith, W. W., Ross, C. A., Dawson, V. L., & Dawson, T. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507360102 · Cited by 1,228 · cited 1×
“Based on these and other studies with established cell lines, it is plausible to propose that PrPC can modulate signaling cascades, in particular stress-protec- tive pathways (for review, see Flechsig and Weissmann, 2004; Roucou and LeBlanc, 2005; Westergard et al, 2007).”
[URE3] as an Altered URE2 Protein: Evidence for a Prion Analog in Saccharomyces cerevisiae
Wickner, R. B. (1994) · Science · doi:10.1126/science.7909170 · Cited by 1,209
Kinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct
Conway, K. A., Rochet, J.-C., Bieganski, R. M., & Lansbury, P. T. (2001) · Science · doi:10.1126/science.1063522 · Cited by 1,127
Polyubiquitin chains: polymeric protein signals
Pickart, C. M., & Fushman, D. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.09.009 · Cited by 1,049
Causal relation between α-synuclein locus duplication as a cause of familial Parkinson's disease
Ibáñez, P., Bonnet, A.-M., Débarges, B., Lohmann, E., Tison, F., Agid, Y., Dürr, A., Brice, A., & Pollak, P. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17104-3 · Cited by 1,044
Legname, G., Baskakov, I. V., Nguyen, H.-O. B., Riesner, D., Cohen, F. E., DeArmond, S. J., & Prusiner, S. B. (2004) · Science · doi:10.1126/science.1100195 · Cited by 1,021
Mackenzie, I. R. A., Bigio, E. H., Ince, P. G., Geser, F., Neumann, M., Cairns, N. J., Kwong, L. K., Forman, M. S., Ravits, J., Stewart, H., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21147 · Cited by 992 · cited 1×
“…and &2008 European Molecular Biology Organization The EMBO Journal VOL 27 | NO 2 | 2008 341 splice-site mutations have now been identified, which all lead to haploinsufficiency (for review, see Kumar-Singh and Van Broeckhoven, 2007; Mackenzie and Rademakers, 2007; van der Zee et al, 2007a).”
Backgroundα-Synuclein Cooperates with CSPα in Preventing Neurodegeneration
Chandra, S., Gallardo, G., Fernández-Chacón, R., Schlüter, O. M., & Südhof, T. C. (2005) · Cell · doi:10.1016/j.cell.2005.09.028 · Cited by 966
Mandelkow, E. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01368-3 · Cited by 953
Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia
Skibinski, G., Parkinson, N. J., Brown, J. M., Chakrabarti, L., Lloyd, S. L., Hummerich, H., Nielsen, J. E., Hodges, J. R., Spillantini, M. G., Thusgaard, T., et al. (2005) · Nature Genetics · doi:10.1038/ng1609 · Cited by 822
Normal host prion protein necessary for scrapie-induced neurotoxicity
Brandner, S., Isenmann, S., Raeber, A., Fischer, M., Sailer, A., Kobayashi, Y., Marino, S., Weissmann, C., & Aguzzi, A. (1996) · Nature · doi:10.1038/379339a0 · Cited by 810
Yang, Y., Gehrke, S., Imai, Y., Huang, Z., Ouyang, Y., Wang, J.-W., Yang, L., Beal, M. F., Vogel, H., & Lu, B. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602493103 · Cited by 798
Oddo, S., Billings, L., Kesslak, J. P., Cribbs, D. H., & LaFerla, F. M. (2004) · Neuron · doi:10.1016/j.neuron.2004.07.003 · Cited by 780
Depleting Neuronal PrP in Prion Infection Prevents Disease and Reverses Spongiosis
Mallucci, G., Dickinson, A., Linehan, J., Klöhn, P.-C., Brandner, S., & Collinge, J. (2003) · Science · doi:10.1126/science.1090187 · Cited by 770
S -Nitrosylation of Parkin Regulates Ubiquitination and Compromises Parkin's Protective Function
Chung, K. K. K., Thomas, B., Li, X., Pletnikova, O., Troncoso, J. C., Marsh, L., Dawson, V. L., & Dawson, T. M. (2004) · Science · doi:10.1126/science.1093891 · Cited by 769
Ou, S. H., Wu, F., Harrich, D., García-Martínez, L. F., & Gaynor, R. B. (1995) · Journal of Virology · doi:10.1128/jvi.69.6.3584-3596.1995 · Cited by 758
Xu, J., Kao, S.-Y., Lee, F. J. S., Song, W., Jin, L.-W., & Yankner, B. A. (2002) · Nature Medicine · doi:10.1038/nm0602-600 · Cited by 757
The emerging shape of the ESCRT machinery
Williams, R. L., & Urbé, S. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2162 · Cited by 748
Ubiquitylation and cell signaling
Haglund, K., & Dikic, I. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600808 · Cited by 734
A Transmembrane Form of the Prion Protein in Neurodegenerative Disease
Hegde, R. S., Mastrianni, J. A., Scott, M. R., DeFea, K. A., Tremblay, P., Torchia, M., DeArmond, S. J., Prusiner, S. B., & Lingappa, V. R. (1998) · Science · doi:10.1126/science.279.5352.827 · Cited by 729
Dopamine covalently modifies and functionally inactivates parkin
LaVoie, M. J., Ostaszewski, B. L., Weihofen, A., Schlossmacher, M. G., & Selkoe, D. J. (2005) · Nature Medicine · doi:10.1038/nm1314 · Cited by 722
A century-old debate on protein aggregation and neurodegeneration enters the clinic
Lansbury, P. T., & Lashuel, H. A. (2006) · Nature · doi:10.1038/nature05290 · Cited by 687
Volles, M. J., Lee, S.-J., Rochet, J.-C., Shtilerman, M. D., Ding, T. T., Kessler, J. C., & Lansbury, P. T. (2001) · Biochemistry · doi:10.1021/bi0102398 · Cited by 682
Kinase activity is required for the toxic effects of mutant LRRK2/dardarin
Greggio, E., Jain, S., Kingsbury, A., Bandopadhyay, R., Lewis, P., Kaganovich, A., van der Brug, M. P., Beilina, A., Blackinton, J., Thomas, K. J., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.04.001 · Cited by 671
Anchorless Prion Protein Results in Infectious Amyloid Disease Without Clinical Scrapie
Chesebro, B., Trifilo, M., Race, R., Meade-White, K., Teng, C., LaCasse, R., Raymond, L., Favara, C., Baron, G., Priola, S., et al. (2005) · Science · doi:10.1126/science.1110837 · Cited by 652
Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping
Buratti, E. (2001) · The EMBO Journal · doi:10.1093/emboj/20.7.1774 · Cited by 631
Kinase activity of mutant LRRK2 mediates neuronal toxicity
Smith, W. W., Pei, Z., Jiang, H., Dawson, V. L., Dawson, T. M., & Ross, C. A. (2006) · Nature Neuroscience · doi:10.1038/nn1776 · Cited by 619
(2004) · doi:10.1002/ana.10846 · Cited by 614
Neuropathology, biochemistry, and biophysics of α‐synuclein aggregation
Uversky, V. N. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04764.x · Cited by 567
Take five—BACE and the γ‐secretase quartet conduct Alzheimer's amyloid β‐peptide generation
Haass, C. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600061 · Cited by 550
Self-citation100 Years and Counting: Prospects for Defeating Alzheimer's Disease
Roberson, E. D., & Mucke, L. (2006) · Science · doi:10.1126/science.1132813 · Cited by 550
TDP-43 in Familial and Sporadic Frontotemporal Lobar Degeneration with Ubiquitin Inclusions
Cairns, N. J., Neumann, M., Bigio, E. H., Holm, I. E., Troost, D., Hatanpaa, K. J., Foong, C., White, C. L., Schneider, J. A., Kretzschmar, H. A., et al. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070182 · Cited by 544
Shmerling, D., Hegyi, I., Fischer, M., Blättler, T., Brandner, S., Götz, J., Rülicke, T., Flechsig, E., Cozzio, A., von Mering, C., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81572-x · Cited by 530
Yao, D., Gu, Z., Nakamura, T., Shi, Z.-Q., Ma, Y., Gaston, B., Palmer, L. A., Rockenstein, E. M., Zhang, Z., Masliah, E., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404161101 · Cited by 515
Loss-of-Function of Human PINK1 Results in Mitochondrial Pathology and Can Be Rescued by Parkin
Exner, N., Treske, B., Paquet, D., Holmström, K., Schiesling, C., Gispert, S., Carballo-Carbajal, I., Berg, D., Hoepken, H.-H., Gasser, T., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0719-07.2007 · Cited by 513
Self-citationLim, K. L., Chew, K. C. M., Tan, J. M. M., Wang, C., Chung, K. K. K., Zhang, Y., Tanaka, Y., Smith, W., Engelender, S., Ross, C. A., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4474-04.2005 · Cited by 503
Tanaka, Y. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.9.919 · Cited by 497
ESCRT-III Dysfunction Causes Autophagosome Accumulation and Neurodegeneration
Lee, J.-A., Beigneux, A., Ahmad, S. T., Young, S. G., & Gao, F.-B. (2007) · Current Biology · doi:10.1016/j.cub.2007.07.029 · Cited by 496
Progranulin is a mediator of the wound response
He, Z., Ong, C. H. P., Halper, J., & Bateman, A. (2003) · Nature Medicine · doi:10.1038/nm816 · Cited by 490
Guo, Q., Fu, W., Sopher, B. L., Miller, M. W., Ware, C. B., Martin, G. M., & Mattson, M. P. (1999) · Nature Medicine · doi:10.1038/4789 · Cited by 489
Neurotoxicity and Neurodegeneration When PrP Accumulates in the Cytosol
Ma, J., Wollmann, R., & Lindquist, S. (2002) · Science · doi:10.1126/science.1073725 · Cited by 487
DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase
Andres-Mateos, E., Perier, C., Zhang, L., Blanchard-Fillion, B., Greco, T. M., Thomas, B., Ko, H. S., Sasaki, M., Ischiropoulos, H., Przedborski, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703219104 · Cited by 479
The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity
Gloeckner, C. J., Kinkl, N., Schumacher, A., Braun, R. J., O'Neill, E., Meitinger, T., Kolch, W., Prokisch, H., & Ueffing, M. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi439 · Cited by 477
(2001) · doi:10.1523/jneurosci.21-24-09549.2001 · Cited by 476
(2002) · doi:10.1016/s0896-6273(02)01125-x · Cited by 473
Messenger RNA regulation: to translate or to degrade
Shyu, A., Wilkinson, M. F., & van Hoof, A. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601977 · Cited by 447
Prions prevent neuronal cell-line death
Kuwahara, C., Takeuchi, A. M., Nishimura, T., Haraguchi, K., Kubosaki, A., Matsumoto, Y., Saeki, K., Matsumoto, Y., Yokoyama, T., Itohara, S., et al. (1999) · Nature · doi:10.1038/22241 · Cited by 441
Volles, M. J., & Lansbury, P. T. (2003) · Biochemistry · doi:10.1021/bi030086j · Cited by 433
The cellular prion protein (PrPC): Its physiological function and role in disease
Westergard, L., Christensen, H. M., & Harris, D. A. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2007.02.011 · Cited by 433
Wille, H., Drewes, G., Biernat, J., Mandelkow, E. M., & Mandelkow, E. (1992) · The Journal of cell biology · doi:10.1083/jcb.118.3.573 · Cited by 421
Snyder, H., Mensah, K., Theisler, C., Lee, J., Matouschek, A., & Wolozin, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208641200 · Cited by 420
Presenilin clinical mutations can affect γ‐secretase activity by different mechanisms
Bentahir, M., Nyabi, O., Verhamme, J., Tolia, A., Horré, K., Wiltfang, J., Esselmann, H., & De Strooper, B. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03578.x · Cited by 415
Proteasomal Inhibition by α-Synuclein Filaments and Oligomers
Lindersson, E., Beedholm, R., Højrup, P., Moos, T., Gai, W., Hendil, K. B., & Jensen, P. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306390200 · Cited by 397
Martins, I. J., Hone, E., Foster, J. K., Sünram-Lea, S. I., Gnjec, A., Fuller, S. J., Nolan, D., Gandy, S. E., & Martins, R. N. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001854 · Cited by 388
Progranulin Mediates Caspase-Dependent Cleavage of TAR DNA Binding Protein-43
Zhang, Y.-J., Xu, Y.-F., Dickey, C. A., Buratti, E., Baralle, F., Bailey, R., Pickering-Brown, S., Dickson, D., & Petrucelli, L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3421-07.2007 · Cited by 371
Podlisny, M. B., Ostaszewski, B. L., Squazzo, S. L., Koo, E. H., Rydell, R. E., Teplow, D. B., & Selkoe, D. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.16.9564 · Cited by 370
Cross-Linking Cellular Prion Protein Triggers Neuronal Apoptosis in Vivo
Solforosi, L., Criado, J. R., McGavern, D. B., Wirz, S., Sánchez-Alavez, M., Sugama, S., DeGiorgio, L. A., Volpe, B. T., Wiseman, E., Abalos, G., et al. (2004) · Science · doi:10.1126/science.1094273 · Cited by 366
Smith, W. W., Jiang, H., Pei, Z., Tanaka, Y., Morita, H., Sawa, A., Dawson, V. L., Dawson, T. M., & Ross, C. A. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi396 · Cited by 365
Assessment of normal and mutant human presenilin function in Caenorhabditis elegans
Levitan, D., Doyle, T. G., Brousseau, D., Lee, M. K., Thinakaran, G., Slunt, H. H., Sisodia, S. S., & Greenwald, I. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14940 · Cited by 358
De Strooper, B. (2007) · EMBO reports · doi:10.1038/sj.embor.7400897 · Cited by 351
TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein
Strong, M. J., Volkening, K., Hammond, R., Yang, W., Strong, W., Leystra-Lantz, C., & Shoesmith, C. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.03.007 · Cited by 349
Yang, Y., Gehrke, S., Haque, M. E., Imai, Y., Kosek, J., Yang, L., Beal, M. F., Nishimura, I., Wakamatsu, K., Ito, S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504610102 · Cited by 341
TDP-43 in the Ubiquitin Pathology of Frontotemporal Dementia With VCP Gene Mutations
Neumann, M., Mackenzie, I. R., Cairns, N. J., Boyer, P. J., Markesbery, W. R., Smith, C. D., Taylor, J. P., Kretzschmar, H. A., Kimonis, V. E., & Forman, M. S. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e31803020b9 · Cited by 334
Interaction of DJ-1 with Daxx inhibits apoptosis signal-regulating kinase 1 activity and cell death
Junn, E., Taniguchi, H., Jeong, B. S., Zhao, X., Ichijo, H., & Mouradian, M. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409635102 · Cited by 321
Fallon, L., Bélanger, C. M. L., Corera, A. T., Kontogiannea, M., Regan-Klapisz, E., Moreau, F., Voortman, J., Haber, M., Rouleau, G., Thorarinsdottir, T., et al. (2006) · Nature Cell Biology · doi:10.1038/ncb1441 · Cited by 317
Neurological Illness in Transgenic Mice Expressing a Prion Protein with an Insertional Mutation
Chiesa, R., Piccardo, P., Ghetti, B., & Harris, D. A. (1998) · Neuron · doi:10.1016/s0896-6273(00)80653-4 · Cited by 310
Davidson, Y., Kelley, T., Mackenzie, I. R. A., Pickering-Brown, S., Du Plessis, D., Neary, D., Snowden, J. S., & Mann, D. M. A. (2007) · Acta Neuropathologica · doi:10.1007/s00401-006-0189-y · Cited by 299
Wang, Q., Song, C., & Li, C.-C. H. (2004) · Journal of Structural Biology · doi:10.1016/j.jsb.2003.11.014 · Cited by 299
Tan, C.-F., Eguchi, H., Tagawa, A., Onodera, O., Iwasaki, T., Tsujino, A., Nishizawa, M., Kakita, A., & Takahashi, H. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0206-9 · Cited by 298
Prions and their partners in crime
Caughey, B., & Baron, G. S. (2006) · Nature · doi:10.1038/nature05294 · Cited by 295
Gosavi, N., Lee, H.-J., Lee, J. S., Patel, S., & Lee, S.-J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208194200 · Cited by 294
Ma, J., & Lindquist, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011578098 · Cited by 294
Norris, E. H., Giasson, B. I., Hodara, R., Xu, S., Trojanowski, J. Q., Ischiropoulos, H., & Lee, V. M.-Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412621200 · Cited by 273
Moehlmann, T., Winkler, E., Xia, X., Edbauer, D., Murrell, J., Capell, A., Kaether, C., Zheng, H., Ghetti, B., Haass, C., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112686799 · Cited by 267
Self-citationFamilial Parkinson's Disease-associated L166P Mutation Disrupts DJ-1 Protein Folding and Function
Olzmann, J. A., Brown, K., Wilkinson, K. D., Rees, H. D., Huai, Q., Ke, H., Levey, A. I., Li, L., & Chin, L.-S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311017200 · Cited by 267
Disease-Associated Prion Protein Oligomers Inhibit the 26S Proteasome
Kristiansen, M., Deriziotis, P., Dimcheff, D. E., Jackson, G. S., Ovaa, H., Naumann, H., Clarke, A. R., van Leeuwen, F. W. B., Menéndez-Benito, V., Dantuma, N. P., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.04.001 · Cited by 263
Li, J., Zhu, M., Manning-Bog, A. B., Di Monte, D. A., & Fink, A. L. (2004) · The FASEB Journal · doi:10.1096/fj.03-0770fje · Cited by 258
Cappai, R., Leck, S., Tew, D. J., Williamson, N. A., Smith, D. P., Galatis, D., Sharpies, R. A., Curtain, C. C., Ali, F. E., Cherny, R. A., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3437fje · Cited by 257
Prion Protein Accumulation and Neuroprotection in Hypoxic Brain Damage
McLennan, N. F., Brennan, P. M., McNeill, A., Davies, I., Fotheringham, A., Rennison, K. A., Ritchie, D., Brannan, F., Head, M. W., Ironside, J. W., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63291-9 · Cited by 252
Ko, H. S., von Coelln, R., Sriram, S. R., Kim, S. W., Chung, K. K. K., Pletnikova, O., Troncoso, J., Johnson, B., Saffary, R., Goh, E. L., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2172-05.2005 · Cited by 247
Proteasomes and ubiquitin are involved in the turnover of the wild-type prion protein
Yedidia, Y. (2001) · The EMBO Journal · doi:10.1093/emboj/20.19.5383 · Cited by 245
Structural Principles of Tau and the Paired Helical Filaments of Alzheimer's Disease
Mandelkow, E., Von Bergen, M., Biernat, J., & Mandelkow, E. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00053.x · Cited by 243 · cited 3×
“These seem to affect the microtubule-binding capacity of tau and/or increase its aggregation (Mandelkow et al, 2007).”
BackgroundMiller, D. W., Ahmad, R., Hague, S., Baptista, M. J., Canet-Aviles, R., McLendon, C., Carter, D. M., Zhu, P.-P., Stadler, J., Chandran, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304272200 · Cited by 236
Perrault, I., Delphin, N., Hanein, S., Gerber, S., Dufier, J.-L., Roche, O., Defoort-Dhellemmes, S., Dollfus, H., Fazzi, E., Munnich, A., et al. (2007) · Human Mutation · doi:10.1002/humu.9485 · Cited by 231
Hampe, C., Ardila-Osorio, H., Fournier, M., Brice, A., & Corti, O. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl131 · Cited by 226
Lethal recessive myelin toxicity of prion protein lacking its central domain
Baumann, F., Tolnay, M., Brabeck, C., Pahnke, J., Kloz, U., Niemann, H. H., Heikenwalder, M., Rülicke, T., Bürkle, A., & Aguzzi, A. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601510 · Cited by 225
Sriram, S. R., Li, X., Ko, H. S., Chung, K. K. K., Wong, E., Lim, K. L., Dawson, V. L., & Dawson, T. M. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi292 · Cited by 223
Moore, D. J., Zhang, L., Dawson, T. M., & Dawson, V. L. (2003) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2003.02265.x · Cited by 222
Neonatal lethality in transgenic mice expressing prion protein with a deletion of residues 105–125
Li, A., Christensen, H. M., Stewart, L. R., Roth, K. A., Chiesa, R., & Harris, D. A. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601507 · Cited by 215
Wang, C., Ko, H. S., Thomas, B., Tsang, F., Chew, K. C. M., Tay, S.-P., Ho, M. W. L., Lim, T.-M., Soong, T.-W., Pletnikova, O., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi413 · Cited by 207
Baumeister, R., Leimer, U., Zweckbronner, I., Jakubek, C., Grünberg, J., & Haass, C. (1997) · Genes and Function · doi:10.1046/j.1365-4624.1997.00012.x · Cited by 203
Self-citationNonsteroidal anti-inflammatory drugs lower Aβ42 and change presenilin 1 conformation
Lleó, A., Berezovska, O., Herl, L., Raju, S., Deng, A., Bacskai, B. J., Frosch, M. P., Irizarry, M., & Hyman, B. T. (2004) · Nature Medicine · doi:10.1038/nm1112 · Cited by 198
Strain-specified characteristics of mouse synthetic prions
Legname, G., Nguyen, H.-O. B., Baskakov, I. V., Cohen, F. E., DeArmond, S. J., & Prusiner, S. B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409079102 · Cited by 196
Pathways by Which Aβ Facilitates Tau Pathology
Blurton-Jones, M., & LaFerla, F. (2006) · Current Alzheimer Research · doi:10.2174/156720506779025242 · Cited by 195
Weihl, C. C., Dalal, S., Pestronk, A., & Hanson, P. I. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi426 · Cited by 195
Wolfe, M. S. (2007) · EMBO reports · doi:10.1038/sj.embor.7400896 · Cited by 192
Parkin genetics: one model for Parkinson's disease
Mata, I. F. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh089 · Cited by 188
Mukherjee, O., Pastor, P., Cairns, N. J., Chakraverty, S., Kauwe, J. S. K., Shears, S., Behrens, M. I., Budde, J., Hinrichs, A. L., Norton, J., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20963 · Cited by 187
Weise, J., Sandau, R., Schwarting, S., Crome, O., Wrede, A., Schulz-Schaeffer, W., Zerr, I., & Bähr, M. (2006) · Stroke · doi:10.1161/01.str.0000217262.03192.d4 · Cited by 186
Biological activities and signaling pathways of the granulin/epithelin precursor.
Zanocco‐Marani, T., Bateman, A., Romano, G., Valentinis, B., He, Z., & Baserga, R. (1999) · PubMed · Cited by 184
Increased Sensitivity to Seizures in Mice Lacking Cellular Prion Protein
Walz, R., Amaral, O. B., Rockenbach, I. C., Roesler, R., Izquierdo, I., Cavalheiro, E. A., Martins, V. R., & Brentani, R. R. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb01583.x · Cited by 183
Cell systems and the toxic mechanism(s) of α-synuclein
Cookson, M. R., & van der Brug, M. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.05.022 · Cited by 173
Parkin Mediates Neuroprotection through Activation of IκB Kinase/Nuclear Factor-κB Signaling
Henn, I. H., Bouman, L., Schlehe, J. S., Schlierf, A., Schramm, J. E., Wegener, E., Nakaso, K., Culmsee, C., Berninger, B., Krappmann, D., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5537-06.2007 · Cited by 173
Self-citationDiverse Effects of Pathogenic Mutations of Parkin That Catalyze Multiple Monoubiquitylation in Vitro
Matsuda, N., Kitami, T., Suzuki, T., Mizuno, Y., Hattori, N., & Tanaka, K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510393200 · Cited by 167
Page, R. M., Baumann, K., Tomioka, M., Pérez-Revuelta, B. I., Fukumori, A., Jacobsen, H., Flohr, A., Luebbers, T., Ozmen, L., Steiner, H., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708754200 · Cited by 165
Self-citationIhara, M., Yamasaki, N., Hagiwara, A., Tanigaki, A., Kitano, A., Hikawa, R., Tomimoto, H., Noda, M., Takanashi, M., Mori, H., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.019 · Cited by 165
Proteasomal Degradation and N-terminal Protease Resistance of the Codon 145 Mutant Prion Protein
Zanusso, G., Petersen, R. B., Jin, T., Jing, Y., Kanoush, R., Ferrari, S., Gambetti, P., & Singh, N. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.23396 · Cited by 165
Berezovska, O., Lleó, A., Herl, L. D., Frosch, M. P., Stern, E. A., Bacskai, B. J., & Hyman, B. T. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0364-05.2005 · Cited by 164
RING finger 1 mutations in Parkin produce altered localization of the protein
Cookson, M. R. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg328 · Cited by 162
Macedo, M. G., Anar, B., Bronner, I. F., Cannella, M., Squitieri, F., Bonifati, V., Hoogeveen, A., Heutink, P., & Rizzu, P. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg304 · Cited by 158
Cellular prion protein neuroprotective function: implications in prion diseases
Roucou, X., & LeBlanc, A. C. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0605-5 · Cited by 158
Mazzulli, J. R., Mishizen-Eberz, A. J., Giasson, B. I., Lynch, D. R., THOMAS, S. A., Nakashima, A., Nagatsu, T., Ota, A., & Ischiropoulos, H. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0896-06.2006 · Cited by 157
TDP-43 in differential diagnosis of motor neuron disorders
Dickson, D. W., Josephs, K. A., & Amador, C. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0234-5 · Cited by 157
Inactivation of Parkin by Oxidative Stress and C-terminal Truncations
Winklhofer, K. F., Henn, I. H., Kay-Jackson, P. C., Heller, U., & Tatzelt, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306769200 · Cited by 155
Self-citationAggravation of ischemic brain injury by prion protein deficiency: Role of ERK-1/-2 and STAT-1
Spudich, A., Frigg, R., Kılıç, E., Kılıç, Ü., Oesch, B., Raeber, A. J., Bassetti, C. L., & Hermann, D. M. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.04.002 · Cited by 150
Schymick, J. C., Yang, Y., Andersen, P. M., Vonsattel, J. P., Greenway, M. J., Momeni, P., Elder, J., Chiò, A., Restagno, G., Robberecht, W., et al. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.109553 · Cited by 147
p97: The Cell's Molecular Purgatory?
Halawani, D., & Latterich, M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.06.003 · Cited by 143 · cited 1×
“…is a multifunctional AAA (ATPases associated with a variety of activities) ATPase, which has been implicated in the ubiqui- tin-proteasome pathway, ER-associated protein degradation (ERAD), membrane fusion and cell-cycle control (for review, see Wang et al, 2004; Halawani and Latterich, 2006).”
BackgroundDoss-Pepe, E., Chen, L., & Madura, K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413591200 · Cited by 143
van der Zee, J., Ber, I. L., Maurer‐Stroh, S., Engelborghs, S., Gijselinck, I., Camuzat, A., Brouwers, N., Vandenberghe, R. R., Sleegers, K., Hannequin, D., et al. (2007) · Human Mutation · doi:10.1002/humu.9484 · Cited by 139
Search for a Prion-Specific Nucleic Acid
Safar, J., Kellings, K., Serban, A. V., Groth, D., Cleaver, J. E., Prusiner, S. B., & Riesner, D. (2005) · Journal of Virology · doi:10.1128/jvi.79.16.10796-10806.2005 · Cited by 136
Siman, R., Reaume, A. G., Savage, M. J., Trusko, S., Lin, Y.-G., Scott, R. W., & Flood, D. G. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-23-08717.2000 · Cited by 133
Wang, C., Tan, J. M. M., Ho, M. W. L., Zaiden, N., Wong, S. H., Chew, C. L. C., Eng, P. W., Lim, T. M., Dawson, T. M., & Lim, K. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03023.x · Cited by 130
Shyu, W., Lin, S., Chiang, M., Ding, D., Li, K.-W., Chen, S.-F., Yang, H.-I., & Li, H. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1115-05.2005 · Cited by 128
Muramoto, T., Dearmond, S., Scott, M. R., Telling, G., Cohen, F., & Prusiner, S. (1997) · Nature Medicine · doi:10.1038/nm0797-750 · Cited by 125
The Role of the Octarepeat Region in Neuroprotective Function of the Cellular Prion Protein
Mitteregger, G., Voško, M. R., Krebs, B., Xiang, W., Kohlmannsperger, V., Nölting, S., Hamann, G. F., & Kretzschmar, H. A. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00061.x · Cited by 125
Ardley, H. C., Scott, G. B., Rose, S. A., Tan, N. G. S., Markham, A. F., & Robinson, P. A. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-02-0078 · Cited by 125
Mechanistic aspects of Parkinson’s disease: α-synuclein and the biomembrane
Beyer, K. (2007) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-007-0014-9 · Cited by 121
Rangel, A., Burgaya, F., Gavín, R., Soriano, E., Aguzzi, A., & del Río, J. A. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21215 · Cited by 120
Pathogenic mutations inactivate parkin by distinct mechanisms
Henn, I. H., Gostner, J. M., Lackner, P., Tatzelt, J., & Winklhofer, K. F. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02854.x · Cited by 117
Self-citationIdentification of Far Upstream Element-binding Protein-1 as an Authentic Parkin Substrate
Ko, H. S., Kim, S. W., Sriram, S. R., Dawson, V. L., & Dawson, T. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c600041200 · Cited by 115
Mean age of onset in familial Alzheimer's disease is determined by amyloid beta 42
Duering, M., Grimm, M. O. W., Grimm, H. S., Schröder, J., & Hartmann, T. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.08.002 · Cited by 112
Seelaar, H., Schelhaas, H. J., Azmani, A., Küsters, B., Rosso, S. M., Majoor‐Krakauer, D. F., de Rijk, M. C., Rizzu, P., ten Brummelhuis, M., van Doorn, P. A., et al. (2007) · Brain · doi:10.1093/brain/awm024 · Cited by 112
Rademakers, R., Cruts, M., Dermaut, B., Sleegers, K., Rosso, S. M., den Broeck, M. V., Backhovens, H., Swieten, J. C. V., van Duijn, C. M., & Broeckhoven, C. V. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001198 · Cited by 111
Association of Bcl-2 with Misfolded Prion Protein Is Linked to the Toxic Potential of Cytosolic PrP
Rambold, A. S., Miesbauer, M., Rapaport, D., Bartke, T., Baier, M., Winklhofer, K. F., & Tatzelt, J. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-01-0083 · Cited by 98
Self-citationTalking Point on the role of presenilin mutations in Alzheimer disease
Strooper, B. D. (2007) · Cited by 97
The molecular genetics and neuropathology of frontotemporal lobar degeneration: recent developments
Mackenzie, I. R., & Rademakers, R. (2007) · Neurogenetics · doi:10.1007/s10048-007-0102-4 · Cited by 95
Wong, E. S. P., Tan, J. M. M., Wang, C., Zhang, Z., Tay, S.-P., Zaiden, N., Ko, H. S., Dawson, V. L., Dawson, T. M., & Lim, K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609466200 · Cited by 92
TDP43 depletion rescues aberrant CFTR exon 9 skipping
Ayala, Y. M., Pagani, F., & Baralle, F. E. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.01.052 · Cited by 90
The effects of oxidative stress on parkin and other E3 ligases
LaVoie, M. J., Cortese, G. P., Ostaszewski, B. L., & Schlossmacher, M. G. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04911.x · Cited by 90
Differential Effects of Parkinson's Disease-associated Mutations on Stability and Folding of DJ-1
Görner, K., Holtorf, E., Odoy, S., Nuscher, B., Yamamoto, A., Regula, J. T., Beyer, K., Haass, C., & Kahle, P. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309204200 · Cited by 87
Self-citationGu, W., Corti, O., Araujo, F., Hampe, C., Jacquier, S., Lücking, C. B., Abbas, N., Duyckaerts, C. J., Rooney, T., Pradier, L., et al. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.08.011 · Cited by 85
Görner, K., Holtorf, E., Waak, J., Pham, T.-T., Weisenhorn, D. M. V., Wurst, W., Haass, C., & Kahle, P. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609821200 · Cited by 85
Self-citationFrontotemporal Lobar Degeneration: Current Concepts in the Light of Recent Advances
Kumar‐Singh, S., & Broeckhoven, C. V. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00055.x · Cited by 82
Muqit, M. M. K., Davidson, S. M., Smith, M. D. P., MacCormac, L. P., Kahns, S., Jensen, P. H., Wood, N. W., & Latchman, D. S. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddh012 · Cited by 82
Accumulation of murine amyloidβ42 in a gene‐dosage‐dependent manner in PS1 ‘knock‐in’ mice
Nakano, Y., Kondoh, G., Kudo, T., Imaizumi, K., Kato, M., Miyazaki, J., Tohyama, M., Takeda, J., & Takeda, M. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00698.x · Cited by 80
Flechsig, E., Hegyi, I., Leimeroth, R., Zuniga, A., Rossi, D., Cozzio, A., Schwarz, P., Rülicke, T., Götz, J., Aguzzi, A., et al. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg285 · Cited by 79
Zuccato, E., Buratti, E., Stuani, C., Baralle, F. E., & Pagani, F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313439200 · Cited by 78
Recent temperature trends in the Antarctic
Turner, J. C., King, J., Lachlan‐Cope, T., & Jones, P. D. (2002) · Nature · doi:10.1038/418291b · Cited by 77
Determinants of the in Vivo Folding of the Prion Protein
Winklhofer, K. F., Heske, J., Heller, U., Reintjes, A., Muranyi, W., Moarefi, I., & Tatzelt, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209942200 · Cited by 73
Self-citationWang, X., Wang, F., Arterburn, L., Wollmann, R., & Ma, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512306200 · Cited by 69
Emerging evidence for the neuroprotective role of α-synuclein
Lee, H., Zhu, X., Takeda, A., Perry, G. L., & Smith, M. A. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.04.024 · Cited by 45
Frontotemporal Lobar Degeneration with Ubiquitin-Positive Inclusions: A Molecular Genetic Update
van der Zee, J., Gijselinck, I., Pirici, D. N., Kumar‐Singh, S., Cruts, M., & Broeckhoven, C. V. (2007) · Neurodegenerative Diseases · doi:10.1159/000101847 · Cited by 26
Progranulin and frontotemporal lobar degeneration
Pickering-Brown, S. M. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0241-6 · Cited by 26
Dumpitak, C., Beekes, M., Weinmann, N., Metzger, S. U., Winklhofer, K. F., Tatzelt, J., & Riesner, D. (2005) · Biological Chemistry · doi:10.1515/bc.2005.131 · Cited by 24
Self-citation
Cited by
The role of apolipoprotein E in Alzheimer's disease
Kim, J., Basak, J. M., & Holtzman, D. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.06.026 · Cited by 1,661
“A similar issue regarding the role of PSEN mutations in AD has been debated recently (Bentahir et al., 2006;Shen and Kelleher, 2007;Winklhofer et al., 2008).”
The proteostasis network and its decline in ageing
Hipp, M. S., Kasturi, P., & Hartl, F. U. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0101-y · Cited by 1,642
α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation
Bartels, T., Choi, J. G., & Selkoe, D. J. (2011) · Nature · doi:10.1038/nature10324 · Cited by 1,263
Mitochondrial dysfunction and oxidative stress in Parkinson's disease
Subramaniam, S. R., & Chesselet, M.-F. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.04.004 · Cited by 913
Mahul-Mellier, A.-L., Burtscher, J., Maharjan, N., Weerens, L., Croisier, M., Kuttler, F., Leleu, M., Knott, G. W., & Lashuel, H. A. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1913904117 · Cited by 710
Metadata
- Authors
- Winklhofer, K. F., Tatzelt, J., & Haass, C.
- Venue
- The EMBO Journal
- Published
- 2008-01-23
- Volume
- 27
- Issue
- 2
- Pages
- 336-349
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- OpenAlex
- W2130303726
- Cited by
- 401
- References
- 188
- FWCI
- 17.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.